AQST - Aquestive Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Aquestive Therapeutics, Inc.
IPO Date: July 23, 2018
Sector: Healthcare
Industry: Drug Manufacturers - Specialty and Generic
Market Cap: $597.44M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.17 | 3.96%
Avg Daily Range (30 D): $0.11 | 2.31%
Avg Daily Range (90 D): $0.12 | 2.64%
Institutional Daily Volume
Avg Daily Volume: 1.02M
Avg Daily Volume (30 D): 2.02M
Avg Daily Volume (90 D): 2.27M
Trade Size
Avg Trade Size (Sh.): 176
Avg Trade Size (Sh.) (30 D): 161
Avg Trade Size (Sh.) (90 D): 164
Institutional Trades
Total Institutional Trades: 374
Avg Institutional Trade: $1.5M
Avg Institutional Trade (30 D): $1.11M
Avg Institutional Trade (90 D): $1.29M
Avg Institutional Trade Volume: .34M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.46M
Avg Closing Trade (30 D): $1.11M
Avg Closing Trade (90 D): $1.16M
Avg Closing Volume: 314.35K
 
News
May 2, 2026 @ 8:00 PM
AQST DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Enco...
Source: Rosen Law Firm
Apr 30, 2026 @ 4:00 PM
Bronstein, Gewirtz & Grossman LLC Urges Atara Biot...
Source: Bronstein, Gewirtz & Grossman Llc
Apr 30, 2026 @ 12:04 AM
Bragar Eagel & Squire, P.C. Reminds Aquestive Ther...
Source: Bragar Eagel & Squire, P.C.
Apr 28, 2026 @ 1:00 PM
Portnoy Law Firm Announces Class Action on Behalf ...
Source: Portnoy Law Firm
Apr 27, 2026 @ 4:00 PM
Bronstein, Gewirtz & Grossman LLC Urges Aquestive ...
Source: Bronstein, Gewirtz & Grossman Llc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.66 $-.18 $-.07
Diluted EPS $-.66 $-.18 $-.07
Revenue $54.09M $13.82M $14.45M
Gross Profit $36.26M $9.8M $10.98M
Net Income / Loss $-78.23M $-22.86M $-8.06M
Operating Income / Loss $-52.75M $-8.22M $-4.2M
Cost of Revenue $17.83M $4.02M $3.47M
Net Cash Flow $37.95M $-12.24M $-10.44M
PE Ratio